| Evan Wolf, MD,PHD | |
|
4505 E Greenstreet Cir, Wasilla, AK 99654-8425 | |
| (907) 376-2020 | |
| (907) 357-3937 |
| Full Name | Evan Wolf |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 26 Years |
| Location | 4505 E Greenstreet Cir, Wasilla, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205801586 | NPI | - | NPPES |
| MD22351 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4915 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wolf Eye Center, Inc. | 7012032949 | 6 |
News Archive
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the Cure®.
Ecron Acunova, a full-service clinical research organization (CRO), with offices across Europe, in India and the US, has strengthened its Eastern European presence further by opening a new office in Moscow, Russia in October 2009.
As the Democratic presidential campaign moves to the battleground of South Carolina this weekend, candidate Pete Buttigieg, the former mayor of South Bend, Indiana, is highlighting his health plan as he seeks to slow the momentum of the front-runner, Vermont Sen. Bernie Sanders.
For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA). Although 5-HT is predominantly known as a neurotransmitter within the central nervous system, new evidence points to additional important functions for serotonin in the periphery.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that new pre-clinical data using proprietary rxRNA™ compounds was presented at the Keystone Symposia's RNA Silencing: Mechanism, Biology and Application held January 14-19 in Keystone, Colorado.
› Verified 4 days ago
| Entity Name | Wolf Eye Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063740363 PECOS PAC ID: 7012032949 Enrollment ID: O20100916000210 |
News Archive
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the Cure®.
Ecron Acunova, a full-service clinical research organization (CRO), with offices across Europe, in India and the US, has strengthened its Eastern European presence further by opening a new office in Moscow, Russia in October 2009.
As the Democratic presidential campaign moves to the battleground of South Carolina this weekend, candidate Pete Buttigieg, the former mayor of South Bend, Indiana, is highlighting his health plan as he seeks to slow the momentum of the front-runner, Vermont Sen. Bernie Sanders.
For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA). Although 5-HT is predominantly known as a neurotransmitter within the central nervous system, new evidence points to additional important functions for serotonin in the periphery.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that new pre-clinical data using proprietary rxRNA™ compounds was presented at the Keystone Symposia's RNA Silencing: Mechanism, Biology and Application held January 14-19 in Keystone, Colorado.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Evan Wolf, MD,PHD 4505 E Greenstreet Cir, Wasilla, AK 99654-8425 Ph: (907) 376-2020 | Evan Wolf, MD,PHD 4505 E Greenstreet Cir, Wasilla, AK 99654-8425 Ph: (907) 376-2020 |
News Archive
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the Cure®.
Ecron Acunova, a full-service clinical research organization (CRO), with offices across Europe, in India and the US, has strengthened its Eastern European presence further by opening a new office in Moscow, Russia in October 2009.
As the Democratic presidential campaign moves to the battleground of South Carolina this weekend, candidate Pete Buttigieg, the former mayor of South Bend, Indiana, is highlighting his health plan as he seeks to slow the momentum of the front-runner, Vermont Sen. Bernie Sanders.
For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA). Although 5-HT is predominantly known as a neurotransmitter within the central nervous system, new evidence points to additional important functions for serotonin in the periphery.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that new pre-clinical data using proprietary rxRNA™ compounds was presented at the Keystone Symposia's RNA Silencing: Mechanism, Biology and Application held January 14-19 in Keystone, Colorado.
› Verified 4 days ago